Insuman Comb 15 (Insulin Human)

• Insuman Comb 15 is used to manage blood glucose in diabetes mellitus, a chronic metabolic disorder.
• Type 1 diabetes mellitus: provides basal and prandial insulin coverage to maintain target glycaemic levels.
• Type 2 diabetes mellitus: assists in achieving glycaemic control when oral agents are insufficient, delivering both rapid and intermediate‑acting insulin.
• Insulin deficiency: supplies exogenous insulin to replace lacking endogenous insulin, supporting metabolic needs.

• Insulin human binds to insulin receptors on peripheral tissues, activating intracellular signaling pathways that increase glucose transporter translocation and glucose uptake, while simultaneously suppressing hepatic gluconeogenesis. The combined regular and NPH components provide both immediate and prolonged insulin activity, facilitating comprehensive glycaemic regulation.

Common Side Effects

• Hypoglycaemia: low blood glucose levels, especially if meals are missed or dosing is excessive.
• Injection site reactions: redness, swelling, or itching at the injection site.
• Weight gain: increased caloric storage due to improved glucose utilization.
• Lipodystrophy: localized fat accumulation or loss at repeated injection sites.
• Edema: mild fluid retention, often in the lower extremities.
• Nausea: occasional gastrointestinal discomfort.

Serious or Rare Side Effects

• Severe hypoglycaemia: can lead to seizures, loss of consciousness, or coma.
• Anaphylactic reaction: rare but potentially life‑threatening allergic response.
• Insulin antibodies: formation may alter insulin effectiveness.
• Lipohypertrophy: pronounced fatty tissue buildup causing erratic insulin absorption.
• Acute allergic dermatitis: widespread rash or hives.
• Hypersensitivity bronchospasm: rare respiratory distress.

Insuman Comb 15 requires careful clinical oversight.

• Dose titration: adjust based on regular blood glucose monitoring and physician guidance.
• Hypoglycaemia risk: educate patients to recognize and treat low glucose promptly.
• Renal impairment: use with caution; dose may need modification.
• Pregnancy: consider only if benefits outweigh potential risks and under medical supervision.
• Driving and operating machinery: avoid if experiencing hypoglycaemic symptoms.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Insuman Comb 15 may interact with several drug classes.

Major Interactions (Avoid)

• Concurrent sulfonylureas: increased risk of severe hypoglycaemia.
• Beta‑blockers: can mask typical hypoglycaemia warning signs.
• MAO inhibitors: unpredictable alterations in glucose control.

Moderate Interactions (Monitor Closely)

• ACE inhibitors: may enhance insulin sensitivity; monitor glucose levels.
• Thiazide diuretics: potential to raise blood glucose; watch for hyperglycaemia.
• Corticosteroids: can increase insulin resistance; adjust dosage as needed.